Kazia Therapeutics Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Kazia Therapeutics Limited - ADR: Is Infosys Ltd. worth buying?
Item: Kazia Therapeutics Limited - ADR
Rating: 1.75825
Author: Trendlyne DVM scores

about

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is ...

13.32 0.20 (1.52%)

174.07% Gain from 52W Low

18,381.7

XNAS Volume

XNAS 17 Jul, 2026 10:35 AM (EDT)

Not Eligible

Expensive Valuation

4.0 / 100

Technically Moderately Bullish

66.3 / 100

1Yr Price target upside is 108%

5 analysts

Kazia Therapeutics Ltd (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..